TOTALLY HARMLESS OR SLOW BURN: HOW DO WE INTERPRET CHANGES IN SERUM CREATININE FROM MOLECULARLY-TARGETED CANCER THERAPIES?

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1742, Poster Board= SUN-016

Susan Ziolkowski Poster Presenter